Cargando…
GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
BACKGROUND AND OBJECTIVE: Liver cancer is a malignancy with a poor prognosis. G protein signaling modulator 2 is mainly related to cell division and cell cycle regulation. In this review, the relationship between G protein signaling modulator 2 and clinical characteristics of patients with liver can...
Autores principales: | Yang, Dingquan, Ji, Fujian, Li, Yanqing, Jiao, Yan, Fang, Xuedong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440740/ https://www.ncbi.nlm.nih.gov/pubmed/32812493 http://dx.doi.org/10.1177/1533033820945817 |
Ejemplares similares
-
Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer
por: Yang, Dingquan, et al.
Publicado: (2020) -
HN1 as a diagnostic and prognostic biomarker for liver cancer
por: Liu, Zhicheng, et al.
Publicado: (2020) -
SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020) -
Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas
por: Wang, Ming, et al.
Publicado: (2021) -
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)